ID
13434
Description
Antibiotic-associated diarrhoea (AAD) is a frequent condition in hospitalised patients receiving antibiotic treatment. The same is true for Clostridium difficile-associated diarrhoea (CDAD) with even more grave consequences of increased morbidity and mortality. The development and evaluation of preventive strategies is one key public health challenge. In the absence of clinically evaluated alternatives, probiotics have been suggested to be beneficial for the prevention of AAD and CDAD. However, data have so far been inconclusive and recently published meta-analyses strongly recommended large state-of-the-art clinical trials on probiotic substances for the prevention of AAD and CDAD. Since the efficacy, side-effects and modes of action of different probiotic bacteria and yeast are strain specific, benefits and risks cannot be generalised. The non-pathogenic yeast Saccharomyces cerevisiae var. boulardii (Sac. boulardii) is considered the most promising probiotic substance for the prevention of AAD and CDAD. We carry out a randomised, placebo controlled, double blind multicentre clinical trial to evaluate Sac. boulardii for the indication of prevention of AAD and CDAD in 1520 adult, hospitalised patients.
Keywords
Versions (2)
- 2/9/16 2/9/16 -
- 2/11/16 2/11/16 -
Uploaded on
February 11, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
SacBo PZ: Case Report Form Hospitalization Documentation Diarrhea - AAD - CDAD DRKS00000084 NCT01143272
SacBo PZ: Case Report Form Hospitalization Documentation Diarrhea - AAD - CDAD NCT01143272
Description
Clinical diagnosis
Description
Bloody stool
Data type
integer
Alias
- UMLS CUI [1]
- C0018932
Description
Abdominal pain/cramp
Data type
integer
Alias
- UMLS CUI [1]
- C0000737
- UMLS CUI [2]
- C0000729
Description
Dehydration
Data type
integer
Alias
- UMLS CUI [1]
- C0011175
Description
Fever
Data type
integer
Alias
- UMLS CUI [1]
- C0015967
Description
Medication
Data type
boolean
Alias
- UMLS CUI [1]
- C0013227
Description
Conservative or surgical therapy for AAD/CDAD
Description
Further therapy for AAD/CDAD. (Antibiotics should only be documented as "medication subject to documentation")
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0578159
- UMLS CUI [1,2]
- C0087111
- UMLS CUI [2,1]
- C0235952
- UMLS CUI [2,2]
- C0087111
Description
If there was further treatment necessary please specify: (1 treatment per line)
Data type
text
Alias
- UMLS CUI [1,1]
- C0578159
- UMLS CUI [1,2]
- C0087111
- UMLS CUI [2,1]
- C0235952
- UMLS CUI [2,2]
- C0087111
Description
Further episode of diarrhea/AAD/CDAD
Description
Further episode of diarrhea/AAD/CDAD or further stool sample acquired? According to the study protocol there must be at least 5 days without any symptoms between 2 episodes of diarrhea.
Data type
boolean
Alias
- UMLS CUI [1]
- C0011991
- UMLS CUI [2]
- C0578159
- UMLS CUI [3]
- C0235952
Similar models
SacBo PZ: Case Report Form Hospitalization Documentation Diarrhea - AAD - CDAD NCT01143272
C0578159 (UMLS CUI [2])
C0235952 (UMLS CUI [3])
C0011008 (UMLS CUI [1,2])
C0430414 (UMLS CUI [2])
C0014245 (UMLS CUI [2])
C0026376 (UMLS CUI [2])
C0000729 (UMLS CUI [2])
C0087111 (UMLS CUI [1,2])
C0235952 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C0087111 (UMLS CUI [1,2])
C0235952 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C0578159 (UMLS CUI [2])
C0235952 (UMLS CUI [3])